MAYNE PHARMA INTERNATIONAL PTY LTD

Alphapharm PTY LTD is a generic drug manufacturing company based in Australia. The company manufactures a wide range of generic pharmaceutical medicines and exports them to over 50 countries. Alphapharm is owned by Mylan Pharmaceuticals, which merged with Upjohn on November 16, 2020, to become Viatris. As a global player in the pharmaceutical industry, Alphapharm plays a significant role in providing affordable and accessible medications to patients worldwide. The company's focus on manufacturing generic medicines allows it to offer cost-effective alternatives to branded drugs, making healthcare more accessible to a broader population. With its extensive network of customers spanning 50 countries, Alphapharm has established itself as a reliable partner for the global pharmaceutical industry.

Aspen Pharmacare Australia is one of the leading pharmaceutical companies in the country, dedicated to improving health and quality of life for the communities they serve. With a diverse portfolio of over 150 prescription and over-the-counter medicine brands, the company is committed to making a positive impact on people's lives. The company's comprehensive range of products includes prescription medicines for various therapeutic areas, such as cardiovascular disease, central nervous system disorders, and gastrointestinal conditions, as well as over-the-counter (OTC) medications for everyday health concerns. This diverse portfolio enables Aspen Pharmacare Australia to cater to the needs of a wide range of patients, from children to adults, across various age groups. As a leading player in the Australian pharmaceutical industry, Aspen Pharmacare Australia is constantly striving to innovate and improve its products and services to meet the evolving healthcare needs of the country. With a strong commitment to quality, safety, and patient care, the company is well-positioned to continue making a meaningful difference in the lives of Australians for years to come.

With an Australian presence dating back more than 70 years, Bristol Myers Squibb Australia is a longstanding contributor to Australia's health and economy. The company has a significant presence in the country, with around 300 employees working across various locations, including its headquarters in Mulgrave, a suburb of Melbourne. This long history of operation suggests that the company has established itself as a reliable partner for the Australian healthcare industry.

Eli Lilly and Company is an American multinational pharmaceutical company that operates globally. With a strong presence in over 125 countries, the company's products are widely available across the world. Headquartered in Indianapolis, Indiana, Eli Lilly and Company has established offices in 18 countries, demonstrating its global reach. The company's global presence allows it to cater to diverse markets and populations, making it one of the largest pharmaceutical companies worldwide.

GlaxoSmithKline (GSK) is a major pharmaceutical and healthcare company operating in Australia. The company is focused on research and development of medications across a wide range of disease areas, with a particular emphasis on respiratory health, pharmaceuticals, and vaccines. With a commitment to scientific integrity and compliance, GSK ensures that all products meet stringent standards. As a global company, GSK has a significant presence in the Australian market, where it plays a key role in developing innovative treatments for various diseases.